133
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Assessment of TREM2 rs75932628 variant’s association with Parkinson’s disease in a Greek population and Meta-analysis of current data

, , , , , , , & show all
Pages 544-548 | Received 07 Mar 2019, Accepted 15 Mar 2020, Published online: 19 Apr 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Dimitrios Rikos, Vasileios Siokas, Alexios-Fotios A. Mentis, Athina-Maria Aloizou, Ioannis Liampas, Zisis Tsouris, Eleni Peristeri, Polyxeni Stamati, Georgios M. Hadjigeorgiou & Efthimios Dardiotis. (2022) TREM2 R47H variant and risk for Alzheimer’s disease: assessment in a Greek population and updated meta-analysis. International Journal of Neuroscience 0:0, pages 1-9.
Read now

Articles from other publishers (10)

Fatima Ez-Zahraa Saad, Aaron Pambu Lelo, Kamal Smimih, Bilal El-Mansoury, Manal lkhanouchi, Souad El Amine & Abdelali Bitar. 2023. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease 182 195 .
Hannah Schwarz, Sarah Bässler, Denise Balta, Eileen Socher, Friederike Zunke & Philipp Arnold. (2022) The role of triggering receptor expressed on myeloid cells 2 in Parkinson’s disease and other neurodegenerative disorders. Behavioural Brain Research 433, pages 113977.
Crossref
Vasileios Siokas, Athina‐Maria Aloizou, Ioannis Liampas, Christos Bakirtzis, Zisis Tsouris, Markos Sgantzos, Panagiotis Liakos, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou & Efthimios Dardiotis. (2021) Myelin‐associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson's disease. Acta Neurologica Scandinavica 145:2, pages 223-228.
Crossref
Asim Hussain, Hamza Rafeeq, Nimra Munir, Zara Jabeen, Nadia Afsheen, Khalil ur Rehman, Muhammad Bilal & Hafiz M. N. Iqbal. (2021) Dendritic Cell–Targeted Therapies to Treat Neurological Disorders. Molecular Neurobiology 59:1, pages 603-619.
Crossref
Xiao-xian Li & Feng Zhang. (2021) Targeting TREM2 for Parkinson’s Disease: Where to Go?. Frontiers in Immunology 12.
Crossref
Lorena Pantaleon, Andre Rinaldi Fukushima, Leonardo Ribeiro de Paula, Guilherme Mendes Ribeiro, Beatriz do Prado Pacca, Juliana Weckx Pena Munoz, Helenice de Souza Spinosa & Esther Lopes Ricci. (2021) Integrative Review Verification of the Influence of Atrazine Exposure on Behavioral, Neurochemical and Parkinsons Disease Disorders. Journal of Biomedical Research & Environmental Sciences 2:10, pages 1044-1058.
Crossref
Vasileios Siokas, Athina-Maria Aloizou, Ioannis Liampas, Zisis Tsouris, Alexios-Fotios A. Mentis, Grigorios Nasios, Dimitra Papadimitriou, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou & Efthimios Dardiotis. (2021) Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis. Molecular Biology Reports 48:3, pages 2601-2610.
Crossref
Vasileios Siokas, Athina-Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Panagiotis Liakos, Daniela Calina, Anca Oana Docea, Aristidis Tsatsakis, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou & Efthimios Dardiotis. (2021) ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson’s Disease. Journal of Clinical Medicine 10:3, pages 381.
Crossref
Dimitrios Rikos, Vasileios Siokas, Tatyana I. Burykina, Nikolaos Drakoulis, Efthimios Dardiotis & Elias Zintzaras. (2021) Replication of chromosomal loci involved in Parkinson’s disease: A quantitative synthesis of GWAS. Toxicology Reports 8, pages 1762-1768.
Crossref
Athina-Maria Aloizou, Vasileios Siokas, Efstathia-Maria Sapouni, Nikoleta Sita, Ioannis Liampas, Alexandros G. Brotis, Valerii N. Rakitskii, Tatyana I. Burykina, Michael Aschner, Dimitrios P. Bogdanos, Aristidis Tsatsakis, Georgios M. Hadjigeorgiou & Efthimios Dardiotis. (2020) Parkinson's disease and pesticides: Are microRNAs the missing link?. Science of The Total Environment 744, pages 140591.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.